Xiaojun Gou

机构：Shanghai University of Traditional Chinese Medicine, Shanghai Traditional Chinese Medicine Hospital

发表论文 7 篇 · 总被引 114 次 · h-index 5

代表论文

• The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease (2022 · Frontiers in Microbiology · 被引 38)
• The Effectiveness of Curcumin, Resveratrol, and Silymarin on MASLD : A Systematic Review and Meta‐Analysis (2024 · Food Science & Nutrition · 被引 22)
• Plant-derived bioactive compounds regulate the NLRP3 inflammasome to treat NAFLD (2022 · Frontiers in Pharmacology · 被引 18)
• Dual Role of Pregnane X Receptor in Nonalcoholic Fatty Liver Disease (2023 · Current Molecular Pharmacology · 被引 16)
• Characteristics of serum bile acid profiles among individuals with metabolic dysfunction-associated steatotic liver disease (2025 · BMC Gastroenterology · 被引 10)
• Qushi Huayu decoction alleviates NAFLD in mice by regulating gut microbiota homeostasis in the gut-liver axis via the pregnane X receptor (2025 · European Journal of Pharmacology · 被引 2)